Abrdn Life Sciences Investors (NYSE:HQL) Increases Dividend to $0.50 Per Share

Abrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Wednesday, November 13th,Wall Street Journal reports. Shareholders of record on Thursday, November 21st will be paid a dividend of 0.50 per share on Friday, January 10th. This represents a $2.00 dividend on an annualized basis and a yield of 13.57%. The ex-dividend date of this dividend is Thursday, November 21st. This is a boost from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49.

Abrdn Life Sciences Investors Trading Down 1.9 %

Abrdn Life Sciences Investors stock traded down $0.28 during mid-day trading on Wednesday, reaching $14.74. 90,155 shares of the company traded hands, compared to its average volume of 92,120. Abrdn Life Sciences Investors has a fifty-two week low of $11.62 and a fifty-two week high of $15.90. The firm’s fifty day moving average is $15.03 and its two-hundred day moving average is $14.64.

Abrdn Life Sciences Investors Company Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.